Probiotic Lactobacillus casei activates innate immunity via NF-κB and p38 MAP kinase signaling pathways

Microbes and Infection

Volumn 8, Issue 4, 2006, Pages 994-1005

  Kim, Yun Gi ^a   Ohta, Toshihisa ^b   Takahashi, Takuya ^b   Kushiro, Akira ^b   Nomoto, Koji ^b   Yokokura, Teruo ^b   Okada, Nobuhiko ^a   Danbara, Hirofumi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Innate immunity; Lactobacillus; Mouse model; Pathogen associated molecular pattern receptors; Probiotics; Signal transduction

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ATCC 27139; ATCC 27139 J1R; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 18; METHYLNITRONITROSOGUANIDINE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; P 65 PROTEIN; PHOSPHOTRANSFERASE; PROBIOTIC AGENT; PROTEIN; SALAZOSULFAPYRIDINE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; CARCINOGENESIS; CONTROLLED STUDY; DRUG MECHANISM; FIBROSARCOMA; IMMUNOREACTIVITY; IMMUNOREGULATION; INNATE IMMUNITY; LACTOBACILLUS CASEI; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SARCOMA CELL; SIGNAL TRANSDUCTION; SPLEEN CELL; UPREGULATION;

ANIMALS; CELLS, CULTURED; CYTOKINES; FIBROSARCOMA; HEAT; IMMUNITY, NATURAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTOBACILLUS CASEI; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROBIAL VIABILITY; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; SPLEEN; TOLL-LIKE RECEPTOR 2;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS CASEI; LISTERIA MONOCYTOGENES;

EID: 33646142052     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.10.019     Document Type: Article

References (59)

1. Lilly D.M., and Stillwell R.H. Probiotics: growth-promoting factors produced by microorganisms. Science 147 (1965) 747-748
2. Kirjavainen P.V., ElNezami H.S., Salminen S.J., Ahokas J.T., and Wright P.F. The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol. Med. Microbiol. 26 (1999) 131-135
3. Gill H.S., Rutherfurd K.J., Prasad J., and Gopal P.K. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83 (2000) 167-176
4. Pessi T., Sutas Y., Hurme M., and Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 30 (2000) 1804-1808
5. Yokokura T., Nomoto K., Shimizu T., and Nomoto K. Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei. Infect. Immun. 52 (1986) 156-160
6. Matsuzaki T., Hashimoto S., and Yokokura T. Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice. Med. Microbiol. Immunol. (Berl) 185 (1996) 157-161
7. Kato I., Kobayashi S., Yokokura T., and Mutai M. Antitumor activity of Lactobacillus casei in mice. Gann 72 (1981) 517-523
8. Hessle C., Andersson B., and Wold A.E. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 68 (2000) 3581-3586
9. Miettinen M., Matikainen S., Vuopio-Varkila J., Pirhonen J., Varkila K., Kurimoto M., and Julkunen I. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66 (1998) 6058-6062
10. Haller D., Blum S., Bode C., Hammes W.P., and Schiffrin E.J. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect. Immun. 68 (2000) 752-759
11. Hessle C., Hanson L.A., and Wold A.E. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immunol. 116 (1999) 276-282
12. Matsuguchi T., Takagi A., Matsuzaki T., Nagaoka M., Ishikawa K., Yokokura T., and Yoshikai Y. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through toll-like receptor 2. Clin. Diagn. Lab. Immunol. 10 (2003) 259-266
13. Miettinen M., Lehtonen A., Julkunen I., and Matikainen S. Lactobacilli and Streptococci activate NF-κB and STAT signaling pathways in human macrophages. J. Immunol. 164 (2000) 3733-3740
14. Ohashi T., Minamishima Y., Yokokura T., and Mutai M. Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus casei. Biotherapy 1 (1989) 89-95
15. Cretney E., Degli-Esposti M.A., Densley E.H., Farrell H.E., Davis-Poynter N.J., and Smyth M.J. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190 (1999) 435-444
16. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R., Yokoyama W.M., and Scalzo A.A. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13483-13488
17. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1 (2001) 135-145
18. Inohara N., and Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3 (2003) 371-382
19. Girardin S.E., Sansonetti P.J., and Philpott D.J. Intracellular vs extracellular recognition of pathogens - common concepts in mammals and flies. Trends Microbiol. 10 (2002) 193-199
20. Medzhitov R., and Janeway Jr. C. The toll receptor family and microbial recognition. Trends Microbiol. 8 (2000) 452-456
21. Li Q., and Verma I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2 (2002) 725-734
22. Schmitz M.L., Bacher S., and Kracht M. IκB-independent control of NF-κB activity by modulatory phosphorylations. Trends Biochem. Sci. 26 (2001) 186-190
23. Bancroft G.J. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5 (1993) 503-510
24. Unanue E.R. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158 (1997) 11-25
25. Trinchieri G., and Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 146 (1995) 423-431
26. Belardelli F., and Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 23 (2002) 201-208
27. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
28. Yokokura T. Phage receptor material in Lactobacillus casei. J. Gen. Microbiol. 100 (1977) 139-145
29. Matsuguchi T., Takagi K., Musikacharoen T., and Yoshikai Y. Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood 95 (2000) 1378-1385
30. Faure E., Thomas L., Xu H., Medvedev A., Equils O., and Arditi M. Bacterial lipopolysaccharide and IFN-γ induce toll-like receptor 2 and toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J. Immunol. 166 (2001) 2018-2024
31. Schwandner R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274 (1999) 17406-17409
32. Liu Y., Wang Y., Yamakuchi M., Isowaki S., Nagata E., Kanmura Y., Kitajima I., and Maruyama I. Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-κB activation. Infect. Immun. 69 (2001) 2788-2796
33. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., and Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
34. Matsumura T., Degawa T., Takii T., Hayashi H., Okamoto T., Inoue J., and Onozaki K. TRAF6-NF-κB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 109 (2003) 127-136
35. Kurt-Jones E.A., Mandell L., Whitney C., Padgett A., Gosselin K., Newburger P.E., and Finberg R.W. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100 (2002) 1860-1868
36. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2. J. Immunol. 163 (1999) 1-5
37. Karlsson H., Hessle C., and Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 70 (2002) 6688-6696
38. Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S., Valvano M.A., Foster S.J., Mak T.W., Nunez G., and Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4 (2003) 702-707
39. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., Moran A.P., Fernandez-Luna J.L., and Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278 (2003) 5509-5512
40. Sakurai H., Suzuki S., Kawasaki N., Nakano H., Okazaki T., Chino A., Doi T., and Saiki I. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278 (2003) 36916-36923
41. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., and Haegeman G. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22 (2003) 1313-1324
42. Jiang X., Takahashi N., Matsui N., Tetsuka T., and Okamoto T. The NF-κB activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278 (2003) 919-926
43. Sizemore N., Lerner N., Dombrowski N., Sakurai H., and Stark G.R. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J. Biol. Chem. 277 (2002) 3863-3869
44. Salomonsson L., Pettersson S., Englund M.C., Wiklund O., and Ohlsson B.G. Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages. Eur. J. Clin. Invest. 32 (2002) 767-774
45. Clark A.R., Dean J.L., and Saklatvala J. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett. 546 (2003) 37-44
46. Takanami-Ohnishi Y., Amano S., Kimura S., Asada S., Utani A., Maruyama M., Osada H., Tsunoda H., Irukayama-Tomobe Y., Goto K., Karin M., Sudo T., and Kasuya Y. Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity. J. Biol. Chem. 277 (2002) 37896-37903
47. Clark A. Post-transcriptional regulation of pro-inflammatory gene expression. Arthritis Res. 2 (2000) 172-174
48. Stokoe D., Campbell D.G., Nakielny S., Hidaka H., Leevers S.J., Marshall C., and Cohen P. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11 (1992) 3985-3994
49. Kotlyarov A., and Gaestel M. Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression?. Biochem. Soc. Trans. 30 (2002) 959-963
50. Mavropoulos A., Sully G., Cope A.P., and Clark A.R. Stabilization of IFN-γ mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells. Blood 105 (2005) 282-288
51. Fotheringham J.A., Mayne M.B., Grant J.A., and Geiger J.D. Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-α mRNA stability and p38 activity. Eur. J. Pharmacol. 497 (2004) 87-95
52. Wang S.W., Pawlowski J., Wathen S.T., Kinney S.D., Lichenstein H.S., and Manthey C.L. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm. Res. 48 (1999) 533-538
53. Rutault K., Hazzalin C.A., and Mahadevan L.C. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-α) mRNA induction. Evidence for selective destabilization of TNF-α transcripts. J. Biol. Chem. 276 (2001) 6666-6674
54. Brook M., Sully G., Clark A.R., and Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. FEBS Lett. 483 (2000) 57-61
55. An H., Yu Y., Zhang M., Xu H., Qi R., Yan X., Liu S., Wang W., Guo Z., Guo J., Qin Z., and Cao X. Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106 (2002) 38-45
56. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60 (1996) 8-26
57. Rawadi G., Ramez V., Lemercier B., and Roman-Roman S. Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: involvement in cytokine synthesis. J. Immunol. 160 (1998) 1330-1339
58. Garcia J., Lemercier B., Roman-Roman S., and Rawadi G. A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-κB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. J. Biol. Chem. 273 (1998) 34391-34398
59. Dziarski R., Jin Y.P., and Gupta D. Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J. Infect. Dis. 174 (1996) 777-785